Apr 08, 2019

Appointment of Catherine London as President of Consilium Strategic Communications US Inc

Posted by


Catherine London, President US, Consilium Strategic Communications

LONDON, UK; 3 April 2019  Consilium Strategic Communications, a global leader in strategic healthcare communications, is pleased to announce that it has opened a US subsidiary and appointed Catherine London as President of Consilium Strategic Communications US Inc (CSC US Inc) to lead the expansion of its global offering into the United States. 

CSC US Inc’s staff will be based in Connecticut, within easy reach of healthcare and financial centres in the Boston and New York areas. The newly formed subsidiary will expand its client base within the US and aims to support Consilium’s current European and global healthcare clients with US media management, strategic communications, financial communications, advocacy relations and transaction support.

Catherine London has more than 23 years of global pharmaceutical and biotechnology experience working with a broad range of start ups and Fortune 100 and 500 companies. Prior to joining Consilium, Catherine served as an Executive Vice President and Head of Corporate Communications and Investor Relations at Bioasis Technologies, Inc. Catherine previously held senior roles in corporate and product communications at companies including Alexion Pharmaceuticals, Inc. and Boehringer Ingelheim Pharmaceuticals, Inc., among others. Her expertise includes executive, corporate, scientific and financial communications, investor relations, public affairs, government and policy communications and business communications. Catherine has also held senior leadership roles at global consulting firms such as Resolute, Ruder Finn and the Chandler Chicco Companies, an inVentiv Health Company, which includes Chamberlain, Chandler Chicco and BioSector 2.

Catherine began her career as a journalist working as a reporter and editor at print and broadcast outlets covering US markets before taking a role as a science journal editor. Catherine then transitioned to public affairs at the American Diabetes Association. Catherine has a BA in Journalism from Auburn University.

Consilium Strategic Communications was launched in 2013 and now has a team of approximately 30 staff in Europe covering investor relations and financial public relations for the healthcare sector with headquarters in London.  

Mary-Jane Elliott, Managing Partner, Consilium Strategic Communications, and Amber Fennell, Co-Founder, said: “We are delighted to announce the appointment of Catherine as our US President and the creation of a stronger Consilium offering in the US. CSC US Inc.,  will support the increasing demand from our global clients for services in this important geography. This is in line with our ambitions to grow our strategic healthcare communications business internationally and expand the range of services we offer as we continue to successfully service our global pharmaceutical, biotech, medical devices and healthtech customer base. 

“With the appointment of Catherine, Consilium’s clients will be able to benefit from the same dedication, proactivity and unrivalled expertise that has driven Consilium’s success since inception. Catherine’s broad experience across the communications spectrum, most notably in media management, from a highly regarded journalist to in-house investor and public relations manager will be invaluable to us as we set out to mirror our European success in the US.”

Catherine London, President US, Consilium Strategic Communications, said: “The Consilium team has built an amazing roster of clients and accomplishments. The passion that each team member brings to work and to truly knowing their clients' business, inside and out, is evident. I am thrilled to be joining Consilium and establishing the US practice, bringing to bear my extensive experience of the biotech, pharmaceutical and healthcare industry. I look forward to working with clients to add value and realize their mission to bring better healthcare and products to the market.”


For more information please contact:

Consilium Strategic Communications


Mary-Jane Elliott / Amber Fennell / Chris Gardner

Tel: +44(0)20 3709 5700,




Catherine London, US President

Tel: +1 917-763-2709


Follow us: @consiliumhc

About Consilium Strategic Communications

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly-skilled team provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects. 

Consilium Strategic Communications US Inc

Consilium represents innovators in the healthcare and biotechnology fields whose science is changing the future of treatments. The Consilium Strategic Communications US Inc offering includes precise executive, corporate, product and financial communications strategies and media relations, reputation building, patient advocacy, health education, social media strategy engagement and activation and crisis communications to deliver sustained results that inspire action and build value.

See all Member News